Effect of SARS-CoV-2 infection and pandemic period on healthcare-associated infections acquired in intensive care units.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 21 06 2022
revised: 11 10 2022
accepted: 16 10 2022
medline: 4 4 2023
pubmed: 29 11 2022
entrez: 28 11 2022
Statut: ppublish

Résumé

To compare the occurrence of healthcare-associated infections acquired in intensive care units (HAI-ICUs) in France among patients with COVID-19 and those without it in 2020 and the latter with that in patients before the COVID-19 pandemic. Multicentre HAI-ICU surveillance network (REA-REZO) data were used to identify 3 groups: 2019 patients (2019Control), a COVID-19 group (2020Cov), and a non-COVID-19 group (2020NonCov). The primary outcome was the occurrence of HAI-ICU (ventilator-associated pneumonia [VAP], bloodstream infections [BSIs], catheter-related bacteraemia). Standardized infection ratios of VAP were calculated for each quarter in 2020 and compared with those in 2019. A total of 30 105 patients were included in 2020: 23 798 in the 2020NonCov group, 4465 in 2020Cov group, and 39 635 patients in the 2019Control group. The frequency of VAP was strikingly greater in the 2020Cov group: 35.6 (33.4-37.8) episodes/1000 days of mechanical ventilation versus 18.4 (17.6-19.2) in the 2020NonCov group. VAP standardized infection ratio was high in 2020 patients, particularly during the 2 quarters corresponding to the 2 waves. BSI/1000 days were more frequent in the 2020Cov group (6.4% [6.4-6.4%] vs. 3.9% [3.8-3.9%] in the 2020NonCov group). VAP and BSI were also more frequent in the 2020NonCov group than in the 2019Control group. The microbial epidemiology was only slightly different. The data presented here indicate that HAI-ICUs were more frequent during the COVID-19 period, whether the patients were admitted for COVID-19 or, to a lesser extent, for another cause. This implies that managing patients with severe disease in a pandemic context carries risks for all patients.

Identifiants

pubmed: 36441042
pii: S1198-743X(22)00537-7
doi: 10.1016/j.cmi.2022.10.023
pmc: PMC9613804
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

530-536

Informations de copyright

Copyright © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Références

Clin Microbiol Infect. 2021 Jan;27(1):47-54
pubmed: 33190794
Intensive Care Med. 2021 Feb;47(2):180-187
pubmed: 33506379
Crit Care Med. 2022 Mar 1;50(3):449-459
pubmed: 34637422
Intensive Care Med. 2021 Jan;47(1):104-106
pubmed: 33068116
Sci Rep. 2021 Aug 13;11(1):16497
pubmed: 34389761
Eur J Anaesthesiol. 2022 May 1;39(5):427-435
pubmed: 35200203
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
J Clin Microbiol. 2022 Mar 16;60(3):e0027621
pubmed: 34346716
Chest. 2021 Aug;160(2):454-465
pubmed: 33857475
Am J Respir Crit Care Med. 2022 Jul 15;206(2):161-169
pubmed: 35537122
Nature. 2021 Feb;590(7844):140-145
pubmed: 33137809
Intensive Care Med. 2018 Dec;44(12):2216-2218
pubmed: 29797028
Infect Control Hosp Epidemiol. 2022 Jan;43(1):12-25
pubmed: 34473013
Intensive Care Med. 2020 Jul;46(7):1303-1325
pubmed: 32514598
Infect Control Hosp Epidemiol. 2022 Jun;43(6):813-815
pubmed: 33706842
ERJ Open Res. 2022 Jul 25;8(3):
pubmed: 35891621
BMJ Open. 2021 Jan 11;11(1):e044640
pubmed: 33431495
Ann Intensive Care. 2021 Jan 29;11(1):20
pubmed: 33512602
Anaesth Crit Care Pain Med. 2021 Aug;40(4):100931
pubmed: 34256165

Auteurs

Alain Lepape (A)

Service d'anesthésie, de Médecine Intensive, de Médecine péri-opératoire et de Réanimation Hospices Civils de Lyon Groupement Sud, Lyon, France; REA-REZO (Surveillance, Infections & Antibiotic Resistance Network in ICU), Hospices Civils de Lyon Groupement Sud, St Genis Laval, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie Lyon, France. Electronic address: alain.lepape@chu-lyon.fr.

Anaïs Machut (A)

REA-REZO (Surveillance, Infections & Antibiotic Resistance Network in ICU), Hospices Civils de Lyon Groupement Sud, St Genis Laval, France; CPias Auvergne Rhône-Alpes, Hôpital Henry Gabrielle, Hospices Civils de Lyon, France.

Cedric Bretonnière (C)

REA-REZO (Surveillance, Infections & Antibiotic Resistance Network in ICU), Hospices Civils de Lyon Groupement Sud, St Genis Laval, France; Unité des Soins Intensifs de Pneumologie, Institut du Thorax, Nantes CHU, Nantes, France.

Arnaud Friggeri (A)

Service d'anesthésie, de Médecine Intensive, de Médecine péri-opératoire et de Réanimation Hospices Civils de Lyon Groupement Sud, Lyon, France; REA-REZO (Surveillance, Infections & Antibiotic Resistance Network in ICU), Hospices Civils de Lyon Groupement Sud, St Genis Laval, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie Lyon, France.

Charles-Hervé Vacheron (CH)

Service d'anesthésie, de Médecine Intensive, de Médecine péri-opératoire et de Réanimation Hospices Civils de Lyon Groupement Sud, Lyon, France; REA-REZO (Surveillance, Infections & Antibiotic Resistance Network in ICU), Hospices Civils de Lyon Groupement Sud, St Genis Laval, France.

Anne Savey (A)

REA-REZO (Surveillance, Infections & Antibiotic Resistance Network in ICU), Hospices Civils de Lyon Groupement Sud, St Genis Laval, France; Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases, Centre International de Recherche en Infectiologie Lyon, France; CPias Auvergne Rhône-Alpes, Hôpital Henry Gabrielle, Hospices Civils de Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH